Nanotherapeutics, founded in 2000, is a specialty pharmaceutical company with an emphasis on the preclinical and early clinical development of novel or modified dosage forms. Nanotherapeutics has created three proprietary drug delivery technologies: NanoQUAD™, NanoDRY™, and NanoCOAT™. These specialized proprietary techniques can improve the release rate and enhance both the rate and extent of drug uptake, thus increasing bioavailability.